Susan Engle
Family · Altooona, PANPI 1467831719
Payments from drug & device makers
Across 121 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$719
- GSK$352
- Bayer$146
- Lilly USA, LLC$143
- Abbott$141
- AstraZeneca$129
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,689100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $719 |
| GSK | 16 | $352 |
| Bayer | 2 | $146 |
| Lilly USA, LLC | 9 | $143 |
| Abbott | 7 | $141 |
| AstraZeneca(2 entities) | 4 | $129 |
| Novo Nordisk | 7 | $127 |
| Tactile Systems Technology Inc | 2 | $104 |
| Boston Scientific | 2 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $72 |
| Amgen | 3 | $67 |
| Biohaven Pharmaceuticals, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 1 | $55 |
| Pfizer | 3 | $54 |
| Novartis | 3 | $54 |
| Inari Medical, Inc. | 1 | $47 |
| Johnson & Johnson | 3 | $41 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $35 |
| Boehringer Ingelheim | 2 | $30 |
| Merck | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| Biogen | 1 | $18 |
| Myovant Sciences Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Cequr Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$121
- TRELEGY ELLIPTA$121
How this compares
$2,689 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 53 | $53,708 |
| JardianceEmpagliflozin | 47 | $39,963 |
| EliquisApixaban | 47 | $37,351 |
| OzempicSemaglutide | 36 | $36,032 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $28,456 |
| FarxigaDapagliflozin Propanediol | 25 | $25,653 |
| LinzessLinaclotide | 12 | $9,146 |
| XareltoRivaroxaban | 17 | $8,951 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 76 | $6,538 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 21 | $4,209 |
| Solifenacin Succinate | 22 | $3,975 |
| Pregabalin | 29 | $2,467 |
| Atorvastatin Calcium | 181 | $2,392 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $1,767 |
| Levothyroxine Sodium | 119 | $1,697 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $143 | $53,70853 claims |
| Boehringer IngelheimJardiance | $30 | $39,96347 claims |
| PfizerEliquis | $54 | $37,35147 claims |
| Novo NordiskOzempic | $127 | $36,03236 claims |
| GSKTrelegy Ellipta | $352 | $28,45636 claims |
| AstraZenecaFarxiga | $129 | $25,65325 claims |
| AbbVieLinzess | $719 | $9,14612 claims |
| Johnson & JohnsonXarelto | $41 | $8,95117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in Altooona
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.